Nan, Daniel, et al. “Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients With Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report”. European Journal of Case Reports in Internal Medicine, vol. 8, no. 10, Oct. 2021, https://doi.org/10.12890/2021_002821.